[1]
M. Schroeder, E. Perez, M. Lares, P. Guzmán, y S. Brito, «Integrated health care, use of psychotropic medications and soy products as alternative in patients who suffer from schizophrenia and metabolic syndrome», SCECD, vol. 2, n.º 2, ago. 2015.